Erasca

ERAS

ERAS Erasca NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ERAS Chart
    See on advanced chart >

    About

    Erasca, Inc. was incorporated at Delaware on July 2, 2018. They are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Their company was...
    • Highlight
      A clinical-stage precision oncology company that develops therapies for RAS/MAPK pathway-driven cancers
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/16/2021
    • Established Date
      07/02/2018
    • Full-time Employees
      126
    • Address
      3115 Merryfield Row Suite 300 San Diego CA 92121
    • Tel
      1-858-4656511
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock